The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge-Reference-Cited by-同舟云学术

The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge

Published:2015-01-14 Issue:270 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Radzio Jessica¹,Spreen William²,Yueh Yun Lan²,Mitchell James¹,Jenkins Leecresia¹,García-Lerma J. Gerardo¹,Heneine Walid¹

Affiliation:

1. Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

2. GlaxoSmithKline, Research Triangle Park, NC 27709, USA.

Abstract

The long-acting GSK744 HIV integrase inhibitor prevents vaginal SHIV infection in pigtail macaques.

Funder

CDC

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference24 articles.

1. UNAIDS report on the global AIDS epidemic 2013 http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.

2. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

3. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

4. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

5. Preexposure Prophylaxis for HIV Infection among African Women

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates;Science Translational Medicine;2023-06-28

2. Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection;Nature Communications;2023-02-09

3. Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in Women;AIDS Research and Human Retroviruses;2022-12-01

4. A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model;Pharmaceutics;2022-08-24

5. Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study;Clinical Infectious Diseases;2022-08-20